BACKGROUND: There is much interest in exploring whether reward-driven feeding can produce druglike plasticity in the brain. The gamma-aminobutyric acid (GABA) system in the nucleus accumbens (Acb) shell, which modulates hypothalamic feeding systems, is well placed to "usurp" homeostatic control of feeding. Nevertheless, it is unknown whether feeding-induced neuroadaptations occur in this system. METHODS: Separate groups of ad libitum-maintained rats were exposed to daily bouts of sweetened-fat intake, predator stress, or intra-Acb shell infusions of either d-amphetamine (2 or 10 μg) or the μ-opioid agonist D-[Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO, 2.5 μg), then challenged with intra-Acb shell infusion of the GABAA agonist, muscimol (10 ng). RESULTS: Exposure to sweetened fat robustly sensitized muscimol-induced feeding. Sensitization was present 1 week after cessation of the palatable feeding regimen but had abated by 2 weeks. Rats exposed to sweetened fat did not show an altered feeding response to food deprivation. Repeated intra-Acb shell infusions of DAMGO (2.5 μg) also sensitized intra-Acb shell muscimol-driven feeding. However, neither repeated intra-Acb shell d-amphetamine infusions (2 or 10 μg) nor intermittent exposure to an aversive stimulus (predator stress) altered sensitivity to muscimol. CONCLUSIONS: Palatable feeding engenders hypersensitivity of Acb shell GABA responses; this effect may involve feeding-induced release of opioid peptides. Heightened arousal, aversive experiences, or increased catecholamine transmission alone are insufficient to produce the effect, and a hunger-induced feeding drive is insufficient to reveal the effect. These findings reveal a novel type of food-induced neuroadaptation within the Acb; possible implications for understanding crossover effects between food reward and drug reward are discussed.
BACKGROUND: There is much interest in exploring whether reward-driven feeding can produce druglike plasticity in the brain. The gamma-aminobutyric acid (GABA) system in the nucleus accumbens (Acb) shell, which modulates hypothalamic feeding systems, is well placed to "usurp" homeostatic control of feeding. Nevertheless, it is unknown whether feeding-induced neuroadaptations occur in this system. METHODS: Separate groups of ad libitum-maintained rats were exposed to daily bouts of sweetened-fat intake, predator stress, or intra-Acb shell infusions of either d-amphetamine (2 or 10 μg) or the μ-opioid agonist D-[Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO, 2.5 μg), then challenged with intra-Acb shell infusion of the GABAA agonist, muscimol (10 ng). RESULTS: Exposure to sweetened fat robustly sensitized muscimol-induced feeding. Sensitization was present 1 week after cessation of the palatable feeding regimen but had abated by 2 weeks. Rats exposed to sweetened fat did not show an altered feeding response to food deprivation. Repeated intra-Acb shell infusions of DAMGO (2.5 μg) also sensitized intra-Acb shell muscimol-driven feeding. However, neither repeated intra-Acb shell d-amphetamine infusions (2 or 10 μg) nor intermittent exposure to an aversive stimulus (predator stress) altered sensitivity to muscimol. CONCLUSIONS: Palatable feeding engenders hypersensitivity ofAcb shell GABA responses; this effect may involve feeding-induced release of opioid peptides. Heightened arousal, aversive experiences, or increased catecholamine transmission alone are insufficient to produce the effect, and a hunger-induced feeding drive is insufficient to reveal the effect. These findings reveal a novel type of food-induced neuroadaptation within the Acb; possible implications for understanding crossover effects between food reward and drug reward are discussed.
Authors: F Lopez; L G Miller; M L Thompson; A Schatzki; S Chesley; D J Greenblatt; R I Shader Journal: Psychopharmacology (Berl) Date: 1990 Impact factor: 4.530
Authors: Eleonora Khaimova; Yakov Kandov; Yuriy Israel; Giuseppe Cataldo; Maria M Hadjimarkou; Richard J Bodnar Journal: Brain Res Date: 2004-11-12 Impact factor: 3.252
Authors: Rudolph Spangler; Knut M Wittkowski; Noel L Goddard; Nicole M Avena; Bartley G Hoebel; Sarah F Leibowitz Journal: Brain Res Mol Brain Res Date: 2004-05-19
Authors: Julio C Diaz; Kate Dunaway; Elizabeth Sheil; Ken Sadeghian; Anthony Auger; Brian A Baldo Journal: Behav Neurosci Date: 2022-04-07 Impact factor: 2.154
Authors: Ryan A Selleck; Juliana Giacomini; Brandon D Buchholtz; Curtis Lake; Ken Sadeghian; Brian A Baldo Journal: Neuropharmacology Date: 2018-08-04 Impact factor: 5.250
Authors: Juliana L Giacomini; Emma Geiduschek; Ryan A Selleck; Ken Sadeghian; Brian A Baldo Journal: Neuropsychopharmacology Date: 2021-07-05 Impact factor: 8.294